The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

Dear J.H.: Metformin, a treatment for diabetes that works mostly by preventing the liver from making sugar, isn't new and has ...

Ozempic can cause common side effects such as abdominal pain, diarrhea, nausea, and vomiting. Serious side effects of Ozempic may include diabetic retinopathy, gallbladder disease, pancreatitis ...

THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...

I am a 75-year-old woman who isn’t prediabetic or diabetic. My BMI is 31.2. My doctor has prescribed a trial of metformin for ...

Wegovy launched here is to support Singapore’s efforts in improving population health: Novo Nordisk Read more at straitstimes ...

More scientific evidence is emerging to show that our gastrointestinal system interacts with our nervous system ...